GLP-1RA therapy is highly effective for glycemic control, weight loss, and cardiometabolic risk reduction
doi: 10.5501/wjv.v10.i5.229 2 BrobergEKHukkanenV
[1] The active ingredient, semaglutide, is a synthetic peptide that does not contain gluten, and the formulation of Wegovy as a pre-filled injection pen means it is unlikely to include gluten-containing excipients
The FDA was sued by the Outsourcing Facilities Association, which represents compounding pharmacies, for taking tirzepatide off the list, while Novo has filed multiple lawsuits against compounders for selling unauthorised semaglutide-containing products
Once reconstituted with bacteriostatic water, the solution must be refrigerated at 2-8C and typically remains stable for up to four weeks
, ,